Growth Metrics

Conmed (CNMD) FCF Payout Ratio (QoQ) (2012 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Conmed 1.06 Bn 1.02 Bn 183.45 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 17.69%
Sep 30, 2025 -51.72%
Jun 30, 2025 61.47%
Mar 31, 2025 4.14%
Dec 31, 2024 21.87%
Sep 30, 2024 -16.82%
Jun 30, 2024 -31.75%
Mar 31, 2024 90.41%
Dec 31, 2023 -20.92%
Sep 30, 2023 -45.32%
Jun 30, 2023 136.66%
Mar 31, 2023 -113.34%
Dec 31, 2022 -211.10%
Sep 30, 2022 -29.84%
Jun 30, 2022 125.89%
Mar 31, 2022 -1,016.51%
Dec 31, 2021 -48.33%
Sep 30, 2021 98.75%
Jun 30, 2021 -38.11%
Mar 31, 2021 -10.78%
Dec 31, 2020 87.56%
Sep 30, 2020 -94.38%
Jun 30, 2020 -49.67%
Mar 31, 2020 3,777.92%
Dec 31, 2019 -8.27%
Sep 30, 2019 -47.57%
Jun 30, 2019 148.01%
Mar 31, 2019 -351.25%
Dec 31, 2018 100.55%
Sep 30, 2018 -15,845.69%
Jun 30, 2018 24.39%
Mar 31, 2018 -18.91%
Dec 31, 2017 -43.48%
Sep 30, 2017 34.92%
Jun 30, 2017 -2.75%
Mar 31, 2017 -26.23%
Dec 31, 2016 134.69%
Sep 30, 2016 -40.25%
Jun 30, 2016 247.73%
Mar 31, 2016 -144.81%
Dec 31, 2015 15.07%
Sep 30, 2015 -34.29%
Jun 30, 2015 64.92%
Mar 31, 2015 109.44%
Dec 31, 2014 -50.73%
Sep 30, 2014 -69.77%
Jun 30, 2014 284.04%
Mar 31, 2014 132.36%
Dec 31, 2013 12.25%
Sep 30, 2013 -46.70%
Jun 30, 2013 -90.30%
Mar 31, 2013 2,006.31%
Dec 31, 2012 -17.32%
Sep 30, 2012 -13.29%